{
  "item1": "partners, including China, particularly due imposition tariffs U.S. retaliatory tariffs those partners); other global events, significantly increased global macroeconomic uncertainty volatility. Sustained macroeconomic uncertainty volatility geopolitical instability could undermine global consumer confidence could continue reduce consumer spending purchasing power, thereby reducing demand Company's products, continue disrupt global supply chains, impacting availability cost transportation, logistics, raw materials, commodities, labor packaging. Furthermore, U.S.",
  "item7": "ITEM 7. MANAGEMENT’S DISCUSSION ANALYSIS FINANCIAL CONDITION RESULTS OPERATIONS information appears under “Management’s Discussion Analysis Financial Condition Results Operations,” Exhibit 99.1, which incorporated herein reference. ITEM 7.A. QUANTITATIVE QUALITATIVE DISCLOSURES ABOUT MARKET RISK information appears under “Quantitative Qualitative Disclosures about Market Risk” “Management’s Discussion Analysis Financial Condition Results Operations,” Exhibit 99.1, which incorporated herein reference.",
  "item2": "percentage net sales, increased 20 basis points current period compared prior period, while dollars essentially flat. increase research development costs percentage net sales primarily due lower net sales current period related ERP transition. Company continues invest product innovation cost savings. Loss divestiture, interest expense, other (income) expense, net effective tax rate earnings Other (income) expense, net Effective tax rate earnings $118 prior period reflected loss divestiture Better Health VMS business."
}